A team of Northwestern investigators led by Peter Penzes, PhD, the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences and director of the Center for Autism and Neurodevelopment, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder (ASD), according to findings published in Molecular Psychiatry
Sermorelin is a synthetic peptide that mimics the body's natural Growth Hormone-Releasing Hormone (GHRH)
Confirm on the dosage calculator
Replace with a research-safe answer explaining that handling, storage, and experimental context should follow laboratory standards, certificate review, and source documentation
A common pragmatic approach is 812 weeks, then a break